 |
Clinical Trials at UCLA
Clinical Trials at UCLA
Cervix
GOG 0237 – Comparative analysis of CA-IX, p16, proliferative markers and human papilloma virus (HPV) in the diagnosis of significant cervical lesions in patients with a cytologic diagnosis of atypical glandular cells (AGC)
Endometrial
Efficacy of multiparametric MRI in endometrial cancer staging
A study of predictors of response to progesterone therapy in patients with endometrial hyperplasia and cancer
GOG 0249 – A phase III trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy in patients with high risk, early stage endometrial cancer
GOG 0261 – A randomized phase III trial of paclitaxel plus carboplatin versus ifosfamide plus paclitaxel in chemotherapy-naïve patients with newly diagnosed stage I-IV persistent or recurrent carcinosarcoma of the uterus or ovary
GOG 0250 – A randomized phase III evaluation of docetaxel and gemcitabine plus G-CSF with bevacizumab verus docetaxel and gemcitabine pus G-CSF with placebo in the treatment of recurrent or advanced leiomyosarcoma of the uterus
Ovarian
Study of PET imaging prior to ovarian cancer surgery
TRIO 014 – A randomized double-blind, placebo controlled multicenter phase II study of adding AMG 479, a fully human monoclonal antibody against insulin-like growth factor type 1 receptor (IGF-1R) to first line chemotherapy in patients with optimally debulked (<1 cm) epithelial ovarian cancer
GOG 0259 – Comparing options for optimal symptom management
General
Tissue bank collection
Study of IL-6 and depression
Contact Us
If you are interested in joining a clinical trial or would like more information regarding clinical trials and/or which trials are currently being performed in our department, please call Anne Wagner, RN (310) 825-6577.
Learn more about Clinical Trials »
